Home  >  Products  >  AKT2 (v-akt murine thymoma viral oncogene homolog 2) Blocking Peptide (the N terminal of protein) (100ug)
AKT2 (v-akt murine thymoma viral oncogene homolog 2) Blocking Peptide (the N terminal of protein) (100ug)

AKT2 (v-akt murine thymoma viral oncogene homolog 2) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-AKT2 antibody (Catalogue #: AVARP02063_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP30467
Size: 100 ug
Weight: 56kDa
Gene: 208
Format: Lyophilized powder
Target: AKT2 belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains. The gene encoding AKT2 was shown to be amplified and overexpressed in 2 of 8 ovarian carcinoma cell lines and 2 of 15 primary ovarian tumors. Over
Alternative names: PKBBETA; PRKBB; RAC-BETA
See Full Product Listings >